Dimensional Fund Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$215M Buy
3,802,930
+481,176
+14% +$28.1M 0.04% 527
2025
Q4
$197M Buy
3,321,754
+1,076,568
+48% +$58.6M 0.04% 572
2025
Q3
$122M Buy
2,245,186
+671,566
+43% +$38.4M 0.03% 907
2025
Q2
$86.5M Buy
1,573,620
+406,125
+35% +$23.9M 0.02% 1130
2025
Q1
$82.5M Buy
1,167,495
+14,582
+1% +$981K 0.02% 1132
2024
Q4
$75.8M Sell
1,152,913
-186,808
-14% -$12.5M 0.02% 1249
2024
Q3
$94.2M Buy
1,339,721
+305,264
+30% +$25.5M 0.02% 1071
2024
Q2
$85.2M Buy
1,034,457
+289,953
+39% +$24.1M 0.02% 1087
2024
Q1
$65M Buy
744,504
+39,551
+6% +$3.54M 0.02% 1275
2023
Q4
$68M Buy
704,953
+71,853
+11% +$6.36M 0.02% 1222
2023
Q3
$56M Sell
633,100
-14,603
-2% -$1.3M 0.02% 1264
2023
Q2
$56.2M Buy
647,703
+33,581
+5% +$3.16M 0.02% 1261
2023
Q1
$59.7M Buy
614,122
+35,630
+6% +$3.69M 0.02% 1196
2022
Q4
$59.9K Buy
578,492
+10,558
+2% +$991K 0.02% 1184
2022
Q3
$48.1M Buy
567,934
+7,370
+1% +$656K 0.02% 1254
2022
Q2
$46.5M Buy
560,564
+6,434
+1% +$512K 0.02% 1344
2022
Q1
$42.7M Buy
554,130
+2,108
+0.4% +$176K 0.01% 1532
2021
Q4
$48.8M Buy
552,022
+26,813
+5% +$2.21M 0.01% 1425
2021
Q3
$40.6M Buy
525,209
+51,547
+11% +$4.07M 0.01% 1569
2021
Q2
$39.5M Buy
473,662
+28,376
+6% +$2.25M 0.01% 1621
2021
Q1
$33.6M Buy
445,286
+16,990
+4% +$1.39M 0.01% 1723
2020
Q4
$37.6M Buy
428,296
+3,919
+0.9% +$311K 0.01% 1599
2020
Q3
$32.3M Buy
424,377
+34,932
+9% +$3.53M 0.01% 1542
2020
Q2
$48M Buy
389,445
+15,040
+4% +$1.49M 0.02% 1228
2020
Q1
$31.6M Buy
374,405
+179
+0% +$15.4K 0.02% 1427
2019
Q4
$31.6M Buy
374,226
+21,728
+6% +$1.64M 0.01% 1785
2019
Q3
$23.8M Buy
352,498
+13,474
+4% +$1.04M 0.01% 1903
2019
Q2
$29M Buy
339,024
+8,925
+3% +$764K 0.01% 1839
2019
Q1
$29.3M Buy
330,099
+20,320
+7% +$1.88M 0.01% 1844
2018
Q4
$26.4M Buy
309,779
+21,009
+7% +$2M 0.01% 1828
2018
Q3
$28M Buy
288,770
+66,986
+30% +$6.69M 0.01% 1926
2018
Q2
$20.9M Sell
221,784
-1,152
-0.5% -$101K 0.01% 2084
2018
Q1
$18.1M Buy
222,936
+21,299
+11% +$1.83M 0.01% 2116
2017
Q4
$18M Buy
201,637
+4,975
+3% +$433K 0.01% 2109
2017
Q3
$18.3M Buy
196,662
+6,093
+3% +$538K 0.01% 2102
2017
Q2
$17.3M Buy
190,569
+2,422
+1% +$220K 0.01% 2101
2017
Q1
$16.5M Buy
188,147
+7,501
+4% +$667K 0.01% 2095
2016
Q4
$15M Buy
180,646
+7,130
+4% +$613K 0.01% 2122
2016
Q3
$16.1M Buy
173,516
+12,317
+8% +$1.16M 0.01% 2049
2016
Q2
$12.5M Buy
161,199
+3,332
+2% +$283K 0.01% 2121
2016
Q1
$13M Buy
157,867
+3,941
+3% +$321K 0.01% 2086
2015
Q4
$16.1M Buy
153,926
+7,529
+5% +$786K 0.01% 1957
2015
Q3
$15.4M Sell
146,397
-852
-0.6% -$114K 0.01% 1957
2015
Q2
$20.1M Buy
147,249
+14,221
+11% +$1.76M 0.01% 1842
2015
Q1
$16.6M Buy
133,028
+2,989
+2% +$317K 0.01% 1946
2014
Q4
$11.8M Buy
130,039
+2,851
+2% +$237K 0.01% 2149
2014
Q3
$9.18M Sell
127,188
-40,033
-24% -$2.63M 0.01% 2254
2014
Q2
$10.4M Sell
167,221
-2,789
-2% -$168K 0.01% 2187
2014
Q1
$11.6M Sell
170,010
-500
-0.3% -$36.8K 0.01% 2065
2013
Q4
$12M Buy
170,510
+164
+0.1% +$11.1K 0.01% 2025
2013
Q3
$12.3M Buy
170,346
+1,296
+0.8% +$86.1K 0.01% 1921
2013
Q2
$9.43M Buy
+169,050
New +$10.5M 0.01% 2049

Other funds holding BMRN